Market Outlook Snapshot Market Dynamics Regional Forecast Country Insights Segment Analysis Competitive Landscape Industry News report.faq_name
On This Report

Numbing Cream Market Size & Forecasts 2026-2035, By Segments (Product Type, Application, Price Range, Distribution Channel, End Use), Growth Opportunities, Innovation Landscape, Regulatory Shifts, Strategic Regional Insights (U.S., Japan, China, South Korea, UK, Germany, France), and Competitive Dynamics (EMLA, Zensa, TKTX, NumbSkin, Dr. Numb)

Report ID: FBI 20437| Published Date: Dec-2025| Format: PDF, Excel
MARKET OUTLOOK

Market Size and Growoth Outlook

Numbing Cream Market size is forecast to climb from USD 3.76 billion in 2025 to USD 6.99 billion by 2035, expanding at a CAGR of over 6.4% during 2026-2035. Industry revenue in 2026 is projected at USD 3.97 billion.

Base Year Value (2025)
USD 3.76 Billion
CAGR (2026-2035)
6.4%
Forecast Year Value (2035)
USD 6.99 Billion
Historical Data Period
2022-2025
Largest Region
North America
Forecast Period
2026-2035

Get more details on this report

Request Free Sample Report
SNAPSHOT

Numbing Cream Market Intelligence Snapshot

Regional Market Dynamics

Segment Momentum

Market Expansion Drivers

Leading Market Participants

FORECAST SNAPSHOT

Global Market Forecast Snapshot

Market Outlook

Regional and Segment Outlook

MARKET DYNAMICS

Market Growth Drivers and Industry Trends

Rising Demand for Topical Anesthetics in Cosmetic Procedures

The numbing cream market is significantly influenced by the escalating demand for topical anesthetics in cosmetic procedures, driven by an increasing number of minimally invasive surgeries and aesthetic treatments. As consumers become more aware of the benefits of procedures such as laser hair removal and dermal fillers, the need for effective pain management solutions has surged. According to the American Society of Plastic Surgeons, the number of cosmetic procedures has seen a steady rise, leading to a greater emphasis on patient comfort. This trend presents strategic opportunities for established players to expand their product lines and for new entrants to innovate with formulations that cater to this growing market segment, enhancing user experience and safety.

Increased Home-Use for Minor Dermatological Treatments

The numbing cream market is also shaped by the growing trend of self-administered dermatological treatments at home. As consumers seek convenience and cost-effective solutions for minor skin issues, products that provide effective pain relief for at-home procedures have gained traction. The rise of e-commerce platforms, as highlighted by the National Retail Federation, has facilitated easier access to these products, enabling consumers to make informed choices. This shift not only opens avenues for established brands to strengthen their online presence but also allows new entrants to tap into niche markets by offering tailored solutions that meet the specific needs of home users, thus broadening their customer base.

Innovation in Long-Acting Formulations and Delivery Methods

The numbing cream market is evolving due to advancements in long-acting formulations and innovative delivery methods that enhance efficacy and user satisfaction. Recent developments in transdermal delivery systems, as reported by the Journal of Clinical Anesthesia, have improved the absorption and duration of pain relief, making these products more appealing to both medical professionals and consumers. This innovation not only addresses the need for prolonged pain management but also aligns with the growing demand for high-quality, effective solutions in both clinical and home settings. Established companies can leverage these advancements to differentiate their offerings, while new entrants can focus on research and development to introduce groundbreaking products that capture consumer interest and loyalty.

Industry Restraints:

Market Fragmentation and Competition

The numbing cream market faces significant challenges due to intense competition and market fragmentation. Numerous small and medium-sized enterprises (SMEs) are entering the market with innovative formulations, which dilutes brand loyalty and complicates market positioning for established players. A report by Grand View Research highlights that the proliferation of new entrants has led to aggressive pricing strategies, further compressing margins for companies like EMLA and LMX4. This competitive landscape not only pressures established firms to innovate continuously but also creates barriers for new entrants who struggle to gain market share against well-established brands. As a result, companies must invest heavily in marketing and R&D to differentiate their products, which can lead to operational inefficiencies and increased costs.

Regulatory Hurdles in Product Approval

Another critical restraint impacting the numbing cream market is the stringent regulatory framework governing the approval of topical anesthetics. Regulatory bodies such as the U.S. Food and Drug Administration (FDA) impose rigorous testing and safety requirements that can delay product launches and increase development costs. For instance, the lengthy approval process for new formulations can take several years, as evidenced by the delayed market entry of certain innovative products highlighted by the FDA in their recent guidelines. These regulatory barriers not only affect the timeline and financial viability of new products but also create a competitive disadvantage for companies that do not have the resources to navigate complex compliance landscapes effectively. Looking ahead, as regulatory scrutiny intensifies over safety and efficacy, particularly in the wake of rising consumer awareness, market participants will need to adapt strategically to maintain compliance while pursuing innovation.

Growth Driver Impact on CAGR Regulatory Influence Geographic Relevance Adoption Rate Impact Timeline
Rising demand for topical anesthetics in cosmetic procedures 1.30% Short term (≤ 2 yrs) North America, Europe (spillover: Asia Pacific) Medium Fast
Increased home-use for minor dermatological treatments 1.00% Medium term (2–5 yrs) Asia Pacific, North America (spillover: Europe) Low Moderate
Innovation in long-acting formulations and delivery methods 0.70% Long term (5+ yrs) Europe, Asia Pacific (spillover: North America) Medium Slow
CUSTOM RESEARCH

Unlock insights tailored to your business with our bespoke market research solutions.

Click to get your customized report now.

Request Customization →
REGIONAL FORECAST

Regional Demand Dynamics

Polymer Modified Bitumen Market
Largest Region
North America
36.75% Market Share in 2025

North America Market Statistics:

North America represented more than 36.75% of the global numbing cream market in 2025, establishing itself as both the largest and fastest-growing region. This leadership is primarily driven by a high demand for cosmetic procedures, which continues to surge as consumers increasingly seek minimally invasive treatments. The region's robust healthcare infrastructure, coupled with advancements in technology and operational capabilities, further enhances the accessibility and effectiveness of numbing creams. Additionally, shifting consumer preferences towards aesthetic enhancements, supported by a culture that embraces beauty and wellness, contribute to the region's dominant position. According to the American Society of Plastic Surgeons, there has been a marked increase in non-surgical cosmetic procedures, underscoring the growing reliance on numbing agents for patient comfort. As North America continues to innovate and adapt to these evolving dynamics, it presents significant opportunities for stakeholders in the numbing cream market.

The United States anchors the North American numbing cream market, driven by its extensive cosmetic and medical procedure landscape. The high demand for cosmetic procedures in the U.S. is reflected in the increasing number of aesthetic treatments performed annually, which often require effective numbing solutions to enhance patient experience. The American Society of Plastic Surgeons reported that nearly 18 million cosmetic procedures were performed in 2019, a trend that has persisted through the pandemic as consumers prioritize self-care and aesthetic satisfaction. Regulatory frameworks in the U.S. also support the growth of this market, with the Food and Drug Administration ensuring the safety and efficacy of numbing agents, thus fostering consumer trust. This strategic environment positions the U.S. as a critical player in the North American numbing cream market, reinforcing the region's overall growth potential.

Canada plays a complementary role in the North American numbing cream market, characterized by a burgeoning demand for cosmetic treatments similar to its southern neighbor. The Canadian Society of Plastic Surgeons indicates a steady rise in the popularity of non-invasive procedures, which necessitate effective numbing products. The Canadian regulatory landscape, while stringent, ensures high safety standards that enhance consumer confidence in numbing creams. Moreover, the cultural acceptance of cosmetic enhancements in urban centers like Toronto and Vancouver drives market growth, as consumers are increasingly willing to invest in their appearance. This trend not only solidifies Canada’s position within the regional framework but also highlights the interconnected nature of the North American market, where collaborative innovation and shared consumer behaviors create a fertile ground for future opportunities in the numbing cream sector.

Asia Pacific Market Analysis:

The Asia Pacific region has emerged as the fastest-growing market for numbing cream, registering rapid growth with a robust CAGR of 7.8%. This remarkable growth is primarily driven by the rising medical tourism sector, which has significantly increased the demand for numbing creams used in various medical and cosmetic procedures. Countries in this region are witnessing a surge in inbound medical tourists seeking advanced healthcare services, often requiring effective pain management solutions, thereby reinforcing the importance of numbing creams in enhancing patient experiences. The increasing disposable income among consumers, coupled with a growing awareness of aesthetic procedures, is further propelling the demand for these products. Notably, the World Health Organization has reported a steady rise in cross-border healthcare activities, highlighting the region's pivotal role in the global healthcare landscape.

Japan stands out as a key player in the numbing cream market, reflecting its advanced healthcare infrastructure and high standards of medical practice. The rise in medical tourism in Japan is attributed to its reputation for cutting-edge medical technologies and high-quality care, attracting international patients seeking various treatments, including cosmetic surgeries. This influx has led to an increased demand for numbing creams, as patients prioritize comfort during procedures. Moreover, Japan's strict regulatory environment ensures that only the safest and most effective products are available, which aligns with consumer preferences for quality and safety. The Japan Medical Association has noted a significant uptick in the number of foreign patients, further solidifying Japan's position in the regional market.

China, another major contributor to the Asia Pacific numbing cream market, showcases a different dynamic driven by its expanding healthcare access and rising consumer spending on health and beauty products. The country's growing middle class is increasingly investing in cosmetic procedures, which has led to a heightened demand for effective numbing solutions. Regulatory reforms aimed at enhancing the safety and efficacy of medical products have also fostered a more favorable environment for numbing creams. According to the National Health Commission of China, there has been a marked increase in the number of aesthetic procedures performed, indicating a robust market for numbing creams. The interplay of rising disposable incomes, coupled with a cultural shift towards cosmetic enhancement, positions China as a vital market within the broader Asia Pacific landscape, offering substantial opportunities for growth in the numbing cream sector.

Europe Market Trends:

The numbing cream market in Europe has maintained a notable presence, characterized by moderate growth driven by increasing consumer awareness and shifting preferences towards minimally invasive procedures. The region benefits from a robust healthcare infrastructure and a high standard of living, which collectively enhance the demand for numbing creams, particularly in dermatological and cosmetic applications. Recent data from the European Medicines Agency highlights a rising trend in outpatient procedures, which has catalyzed growth in the numbing cream sector. Furthermore, sustainability priorities are influencing product formulations, as consumers increasingly favor eco-friendly options, thereby reshaping market dynamics. The ongoing digital transformation in healthcare delivery is also paving the way for innovative distribution channels, presenting significant opportunities for stakeholders in the numbing cream market to capitalize on evolving consumer behaviors and preferences.

Germany plays a pivotal role in the European numbing cream market, exhibiting strong growth driven by its advanced healthcare system and a growing aesthetic medicine sector. The increasing prevalence of skin-related procedures has led to heightened demand for effective numbing solutions, as reported by the German Federal Ministry of Health. Regulatory support for innovative healthcare products is fostering a competitive landscape that encourages research and development, as seen with companies like HARTMANN GROUP, which are investing in new formulations. This environment not only enhances consumer access to advanced numbing creams but also positions Germany as a key player in shaping regional trends, thereby amplifying opportunities for growth in the broader European market.

France, similarly, has emerged as a significant contributor to the numbing cream market, driven by a cultural inclination towards beauty and wellness. The increasing adoption of aesthetic treatments has spurred demand for numbing creams, with the French National Agency for the Safety of Medicines and Health Products reporting a surge in requests for dermal procedures. This cultural emphasis on personal care and beauty innovations has led to heightened competition among local manufacturers, such as Pierre Fabre, which are adapting their offerings to meet evolving consumer preferences. The strategic implications of France's robust market position highlight its potential to influence regional trends, making it an attractive market for investment and innovation in the numbing cream sector.

Parameter North America Asia Pacific Europe Latin America MEA
Innovation Hub i Scale Nascent Developing Advanced
Cost-Sensitive Region i Scale Low Medium High
Regulatory Environment i Scale Restrictive Neutral Supportive
Demand Drivers i Scale Weak Moderate Strong
Development Stage i Scale Emerging Developing Developed
Adoption Rate i Scale Low Medium High
New Entrants / Startups i Scale Sparse Moderate Dense
Macro Indicators i Scale Weak Stable Strong
COUNTRY INSIGHTS

Key Country Insights

United States 🇺🇸

Procedure Comfort Focus

Demand in the U.S. is supported by dermatology, cosmetic, and outpatient procedures where patient comfort remains a priority. Manufacturers emphasize clinically validated formulations, convenient application formats, and compliance with healthcare and consumer safety expectations.

Germany 🇩🇪

Clinical Application Standards

Germany prioritizes numbing creams that align with stringent medical quality requirements across hospitals, dental practices, and aesthetic clinics. Suppliers focus on consistent product performance, regulatory compliance, and professional distribution channels.

Japan 🇯🇵

Precision Care Solutions

Japan emphasizes numbing creams suited for minimally invasive procedures and high patient care standards. Product developers concentrate on skin-friendly formulations, controlled application, and compatibility with advanced cosmetic and medical treatments.

South Korea 🇰🇷

Aesthetic Treatment Support

South Korea's active cosmetic treatment sector encourages demand for numbing creams designed for laser procedures, skin therapies, and aesthetic interventions. Companies prioritize rapid onset, patient convenience, and formulations tailored for frequent clinical use.

France 🇫🇷

Dermatology Integration

France integrates numbing creams into dermatology and aesthetic care where patient experience and product quality are closely evaluated. Market participants emphasize prescription support, professional recommendations, and reliable topical anesthetic performance.

Italy 🇮🇹

Outpatient Care Demand

Italy supports wider use of numbing creams across dental clinics, dermatology practices, and minor outpatient procedures. Suppliers focus on practical packaging, dependable effectiveness, and products that fit routine clinical workflows.

SEGMENT ANALYSIS

Segment Leadership and Growth Trends

Numbing Cream Market Share (%), Product Type, 2025

Topical anesthetic creams
Topical analgesics
Others

Go beyond the chart, access full insights & data tables

Request Free Sample Report

Analysis by Product Type

The numbing cream market for topical anesthetic creams dominated the segment with a commanding 63.05% share in 2025. This leadership is primarily attributed to the high efficacy of these creams in numbing for cosmetic and medical procedures, which has significantly driven demand among both healthcare professionals and consumers. Additionally, the growing trend towards minimally invasive treatments has heightened the preference for effective numbing solutions, aligning with the increasing focus on patient comfort and satisfaction. Established firms like EMLA and LMX-4 have set industry standards, while emerging players can leverage advancements in formulation technology to create competitive products. Given the ongoing evolution in cosmetic and medical practices, this segment is poised to remain relevant as innovations continue to enhance product performance and application versatility.

Analysis by Application

The numbing cream market for cosmetic procedures captured over 46.35% share of the application segment in 2025. This segment's prominence is driven by the rising popularity of minimally invasive beauty treatments, which require effective numbing solutions to enhance patient experience. As consumer preferences shift towards aesthetic procedures that minimize recovery time, the demand for reliable numbing creams has surged, supported by endorsements from dermatological associations such as the American Academy of Dermatology. Additionally, the increasing societal acceptance of cosmetic enhancements fosters a robust market environment, creating strategic opportunities for both established brands and new entrants to innovate. The segment's relevance is expected to persist as beauty trends evolve, further integrating numbing solutions into routine cosmetic practices.

Analysis by Price Range

The numbing cream market in the mid-price range held a significant 51.5% share in 2025, reflecting a balance between affordability and efficacy for both professional and home use. This segment's success is largely due to its ability to meet diverse consumer needs without compromising on quality, appealing to a broad audience looking for effective pain relief solutions. Market dynamics, influenced by consumer purchasing power and preferences for value-driven products, have propelled mid-range offerings as a favored choice among users. Companies like Lidocaine Plus have capitalized on this trend by providing high-quality products at competitive prices. As the demand for accessible pain management solutions continues to grow, the mid-price segment is likely to maintain its stronghold, driven by ongoing innovations and consumer education.

Segment Sub-Segment Largest Segment Fastest Growing
Product Type Topical anesthetic creams, Topical analgesics, Others
Application Cosmetic procedure, Medical purposes, Pain management
Price Range Low, Mid, High
Distribution Channel Online retail, Pharmacies and drug stores, Medical supply distributors
End Use Home use, Hospitals and clinics, Beauty parlours, Others
Competitive Landscape

Competitive Landscape and Market Positioning

Key players in the numbing cream market include EMLA, Zensa, TKTX, NumbSkin, Dr. Numb, UberNumb, Numb Master, Painless Tattoo, Lidocaine Plus, and Numbify. These companies are pivotal in shaping the landscape of topical anesthetics, each contributing unique formulations and approaches that cater to diverse consumer needs. EMLA, for instance, is recognized for its clinically validated formulations, while Zensa and UberNumb have carved out significant market share through targeted marketing strategies and customer engagement. Similarly, TKTX and NumbSkin leverage their regional strengths, with TKTX being particularly influential in the Asian market due to its widespread acceptance among tattoo artists and beauty professionals. The prominence of these players is further underscored by their commitment to quality and innovation, which enhances their competitive positioning in a growing market.

The competitive environment within the numbing cream market is characterized by dynamic initiatives that enhance the positioning of the leading players. Collaborations between companies and healthcare professionals have fostered a deeper understanding of consumer preferences, leading to the development of tailored products that meet specific needs. For instance, the introduction of new formulations by brands such as Numbify and Dr. Numb reflects a proactive approach to consumer feedback and market demands. Additionally, strategic alliances have emerged to facilitate knowledge sharing and technological advancements, positioning these companies as frontrunners in innovation. This landscape of continual improvement and adaptation not only drives competitiveness but also encourages a culture of excellence in product development across the market.

Strategic / Actionable Recommendations for Regional Players

In North America, a focus on building partnerships with dermatology clinics and aesthetic practitioners could enhance market penetration. Collaborating with healthcare professionals can not only validate product efficacy but also foster trust among consumers, ultimately driving sales in a highly competitive environment.

In the Asia Pacific region, exploring emerging technologies in product formulation could present a significant opportunity for growth. By investing in research and development to create more effective and safer numbing solutions, companies can differentiate themselves and capture the attention of both consumers and professionals in the beauty and tattoo industries.

For Europe, targeting high-growth sub-segments such as at-home beauty treatments and tattoo care can provide avenues for expansion. Engaging with local influencers and beauty experts to promote these products can enhance visibility and consumer interest, effectively responding to the evolving landscape of beauty and personal care.

Company Market Share Company Revenue Revenue CAGR (%) Product Portfolio Geographic Presence Innovation / R&D Focus Strategic Developments
No companies available.
🔒 This section is available as a standalone purchase. Buy only the data you need. Inquire Before Buying
Industry News

Industry Development/News

Company Name Date Key Development
Report Customization

Explore This Report

Click a section of the wheel — or its numbered marker — to preview the custom segmentation, custom table of contents, or related reports available for this market.

1 report.custom report.segments 2 Custom TOC 3 Related Reports

Numbing Cream Market — Custom Segments

Segment Sub-Segment
No segment data available.

Numbing Cream Market — report.custom

Custom Chapter Custom Details
No custom TOC data available.

Need a different cut of the data?

Request Custom Research
report.faq_name

How much revenue does the numbing cream market generate?

The market revenue for numbing cream is anticipated at USD 3.97 billion in 2026.

What is the forecasted size of the numbing cream industry?

Numbing Cream Market size is estimated to increase from USD 3.76 billion in 2025 to USD 6.99 billion by 2035, supported by a CAGR exceeding 6.4% during 2026-2035.

What is the leading region in terms of numbing cream industry share?

North America region acquired more than 36.75% revenue share in 2025, led by high demand for cosmetic procedures.

Who is driving the fastest regional growth in the numbing cream sector?

Asia Pacific region will witness more than 7.8% CAGR during the forecast period, driven by rising medical tourism.

How does topical anesthetic creams segment fare in the numbing cream industry?

Achieving a 63.05% share in 2025, the topical anesthetic creams segment maintained its lead in the numbing cream market, driven by high efficacy in numbing for cosmetic and medical procedures.

What share does cosmetic procedure segment hold in the numbing cream sector as of 2025?

The cosmetic procedure segment recorded a 46.35% market share in 2025, fueled by the rising popularity of minimally invasive beauty treatments boosting usage.

Where is the mid segment seeing the strongest adoption within the numbing cream industry?

Achieving a 51.5% share, the mid segment led the numbing cream market in 2025, propelled by affordable pricing balancing efficacy for professional and home use.

What are the prominent companies operating in the numbing cream landscape?

The top participants in the numbing cream market are EMLA (Sweden), Zensa (USA), TKTX (China), NumbSkin (India), Dr. Numb (Canada), UberNumb (USA), Numb Master (Australia), Painless Tattoo (UK), Lidocaine Plus (Germany), Numbify (USA).
Testimonials

Our Clients

"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."

Quality Assurance Manager

"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."

R&D Manager

"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."

Senior Marketing Manager
THE RESEARCH BEHIND THIS REPORT

Our Research Team & Methodology

Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.

THIS REPORT'S RESEARCH VERTICAL

Research Team Overview

♢
This report was prepared by the Healthcare & Medical Devices Research Team at Fundamental Business Insights, a dedicated research group specializing in the global healthcare and medical technology industry. Our analysts continuously monitor advancements in medical technologies, clinical adoption trends, regulatory developments, reimbursement policies, healthcare infrastructure investments, competitive strategies, and evolving patient care requirements to deliver timely and reliable market intelligence. The research is developed using a structured methodology that combines primary discussions with healthcare stakeholders, company financial disclosures, regulatory publications, clinical literature, government healthcare databases, medical associations, and other authoritative secondary sources. Market estimates are validated through multiple research techniques, including top-down and bottom-up analysis, before undergoing an internal quality review to ensure accuracy, consistency, and methodological integrity prior to publication.

Prepared by the Healthcare & Medical Devices Research Team

10+
Industry Verticals
100+
Countries Analyzed
5–7
Days Standard
Delivery
12k+
Research Reports
Published
On-
Demand
Customized Research
Available
6
Months Analyst
Support
PDF + XLS
Report Deliverables

Trust & Compliance

☷D&B D-U-N-S
♢GDPR & CCPA Compliant
♙ISO 9001 Certified (ISO 9001:2015)
♙SSL Encryption
▭Secure Payments
✓Confidential Handling

Research Domains

10 coverage areas
Medical Devices & Equipment Diagnostic Imaging Clinical Diagnostics Digital Health & Telemedicine Patient Monitoring Systems Surgical & Minimally Invasive Technologies Healthcare IT & Data Systems Biotechnology & Life Sciences Pharmaceutical Technologies Healthcare Delivery & Services

Research Intelligence

Executive Leadership
Product & Technology Experts
Manufacturing & Operations Leaders
Procurement & Supply Chain Professionals
Sales & Commercial Executives
Channel Partners & Distribution Networks
Enterprise Buyers & End Users
Industry Consultants & Regulatory Experts

Research Workflow & Quality Assurance

📥
01

Data Collection

Verified information gathered through primary and secondary research.

🔍
02

Data Triangulation

Cross-validation using multiple independent data sources.

📈
03

Forecast Modelling

Market estimates developed using historical trends and analytical models.

👨‍💼
04

Analyst Validation

Findings reviewed by domain experts for accuracy and consistency.

📝
05

Editorial & Quality Review

Final editorial, quality, and compliance checks before publication.

✅
06

Final Publication

Released after successful completion of the internal review process.

Report Coverage

📊 Market Assessment

  • Market Size & Forecast
  • Market Segmentation
  • Regional Analysis
  • Growth Drivers & Challenges
  • Market Dynamics

🏢 Competitive Intelligence

  • Competitive Landscape
  • Company Profiles
  • Competitive Benchmarking
  • Mergers & Acquisitions
  • Market Share Analysis or Key Company Strategies

🔍 Strategic Analysis

  • Value Chain Analysis
  • Porter's Five Forces
  • PESTLE Analysis
  • Pricing Trends
  • Supply-Demand Analysis

🚀 Future Outlook

  • Technology Landscape
  • Regulatory Landscape
  • Investment & Funding Landscape
  • Emerging Opportunities
  • Future Market Outlook

Have a question about this report or need a custom scope?

Request Customization
License

Select License Type

Single User
US$ 4,250
Buy Now
Corporate User
US$ 6,150
Buy Now

Want this data scoped to your exact question?

Tell us the segments, regions, or competitors you need answered — an analyst will confirm scope before any custom work starts.

Talk to an Analyst →